PROTEZIONE DA PARTE DEI BLOCCANTI DELLA PEROSSIDAZIONE DELLE LIPOPROTEINE UMANE A BASSA DENSITA INDOTTA DAI RADICALI LIBERI DELL'OSSIGENO

Translated title of the contribution: Protection by β-blockers against oxygen radical-induced peroxidation of human low density lipoproteins

C. Napoli, G. Ambrosio, P. Chiariello, G. Palumbo, M. Chiariello

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Previous studies in other systems have shown that β-receptor blockers may effectively inhibit oxygen radical-induced lipid peroxidation. On the other hand, it has been recently proposed that oxygen free radicals can induce peroxidation of human low density lipoproteins (LDL), and that peroxidized LDL may be an atherogenic stimulus. Chemically modified LDL are internalized by macrophages via a specific cell surface receptor that was termed the scavenger receptor. This phenomenon may induce foam cells transformation in vivo. In the present study we investigated whether β-blockers may reduce oxygen radical-mediated LDL peroxidation. Purified human LDL were oxidized by exposure to oxygen free radicals generated by xanthine (0.2 mM) and xanthine oxidase (100 mU) at 37°C after a pre-incubation (30 min) in presence of different concentrations (from 1 to 30 μM) of acebutolol, metoprolol or propranolol, three agents with a different degree of lipophilicity. Peroxidation was measured from malonyldihaldehyde (MDA) production. Data have shown a significant percent inhibition of MDA formation in presence of β-blockers (from 33 to 85%). Thus, β-blockers reduced peroxidation of human LDL in vitro at clinically relevant concentrations. The order of potency appears to follow the degree of lipophilicity. These data suggest that, although β-blockers are known to adversely effect lipid metabolism, these agents might on the other hand prevent atherogenesis via a mechanism of inhibition of LDL peroxidation in vivo and reduced foam cells formation.

Original languageItalian
Pages (from-to)361-366
Number of pages6
JournalGiornale Italiano di Cardiologia
Volume24
Issue number4
Publication statusPublished - 1994

Fingerprint

LDL Lipoproteins
Reactive Oxygen Species
Foam Cells
Free Radicals
Acebutolol
Scavenger Receptors
Metoprolol
Xanthine
Xanthine Oxidase
Cell Surface Receptors
Lipid Metabolism
Propranolol
Lipid Peroxidation
Atherosclerosis
Macrophages

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

PROTEZIONE DA PARTE DEI BLOCCANTI DELLA PEROSSIDAZIONE DELLE LIPOPROTEINE UMANE A BASSA DENSITA INDOTTA DAI RADICALI LIBERI DELL'OSSIGENO. / Napoli, C.; Ambrosio, G.; Chiariello, P.; Palumbo, G.; Chiariello, M.

In: Giornale Italiano di Cardiologia, Vol. 24, No. 4, 1994, p. 361-366.

Research output: Contribution to journalArticle

@article{32e64969afe545b897ae75a1eff07163,
title = "PROTEZIONE DA PARTE DEI BLOCCANTI DELLA PEROSSIDAZIONE DELLE LIPOPROTEINE UMANE A BASSA DENSITA INDOTTA DAI RADICALI LIBERI DELL'OSSIGENO",
abstract = "Previous studies in other systems have shown that β-receptor blockers may effectively inhibit oxygen radical-induced lipid peroxidation. On the other hand, it has been recently proposed that oxygen free radicals can induce peroxidation of human low density lipoproteins (LDL), and that peroxidized LDL may be an atherogenic stimulus. Chemically modified LDL are internalized by macrophages via a specific cell surface receptor that was termed the scavenger receptor. This phenomenon may induce foam cells transformation in vivo. In the present study we investigated whether β-blockers may reduce oxygen radical-mediated LDL peroxidation. Purified human LDL were oxidized by exposure to oxygen free radicals generated by xanthine (0.2 mM) and xanthine oxidase (100 mU) at 37°C after a pre-incubation (30 min) in presence of different concentrations (from 1 to 30 μM) of acebutolol, metoprolol or propranolol, three agents with a different degree of lipophilicity. Peroxidation was measured from malonyldihaldehyde (MDA) production. Data have shown a significant percent inhibition of MDA formation in presence of β-blockers (from 33 to 85{\%}). Thus, β-blockers reduced peroxidation of human LDL in vitro at clinically relevant concentrations. The order of potency appears to follow the degree of lipophilicity. These data suggest that, although β-blockers are known to adversely effect lipid metabolism, these agents might on the other hand prevent atherogenesis via a mechanism of inhibition of LDL peroxidation in vivo and reduced foam cells formation.",
keywords = "β-blockers, LDL, oxygen radicals, peroxidation",
author = "C. Napoli and G. Ambrosio and P. Chiariello and G. Palumbo and M. Chiariello",
year = "1994",
language = "Italian",
volume = "24",
pages = "361--366",
journal = "Giornale Italiano di Cardiologia",
issn = "0046-5968",
publisher = "Societa Italiana di Cardiologia",
number = "4",

}

TY - JOUR

T1 - PROTEZIONE DA PARTE DEI BLOCCANTI DELLA PEROSSIDAZIONE DELLE LIPOPROTEINE UMANE A BASSA DENSITA INDOTTA DAI RADICALI LIBERI DELL'OSSIGENO

AU - Napoli, C.

AU - Ambrosio, G.

AU - Chiariello, P.

AU - Palumbo, G.

AU - Chiariello, M.

PY - 1994

Y1 - 1994

N2 - Previous studies in other systems have shown that β-receptor blockers may effectively inhibit oxygen radical-induced lipid peroxidation. On the other hand, it has been recently proposed that oxygen free radicals can induce peroxidation of human low density lipoproteins (LDL), and that peroxidized LDL may be an atherogenic stimulus. Chemically modified LDL are internalized by macrophages via a specific cell surface receptor that was termed the scavenger receptor. This phenomenon may induce foam cells transformation in vivo. In the present study we investigated whether β-blockers may reduce oxygen radical-mediated LDL peroxidation. Purified human LDL were oxidized by exposure to oxygen free radicals generated by xanthine (0.2 mM) and xanthine oxidase (100 mU) at 37°C after a pre-incubation (30 min) in presence of different concentrations (from 1 to 30 μM) of acebutolol, metoprolol or propranolol, three agents with a different degree of lipophilicity. Peroxidation was measured from malonyldihaldehyde (MDA) production. Data have shown a significant percent inhibition of MDA formation in presence of β-blockers (from 33 to 85%). Thus, β-blockers reduced peroxidation of human LDL in vitro at clinically relevant concentrations. The order of potency appears to follow the degree of lipophilicity. These data suggest that, although β-blockers are known to adversely effect lipid metabolism, these agents might on the other hand prevent atherogenesis via a mechanism of inhibition of LDL peroxidation in vivo and reduced foam cells formation.

AB - Previous studies in other systems have shown that β-receptor blockers may effectively inhibit oxygen radical-induced lipid peroxidation. On the other hand, it has been recently proposed that oxygen free radicals can induce peroxidation of human low density lipoproteins (LDL), and that peroxidized LDL may be an atherogenic stimulus. Chemically modified LDL are internalized by macrophages via a specific cell surface receptor that was termed the scavenger receptor. This phenomenon may induce foam cells transformation in vivo. In the present study we investigated whether β-blockers may reduce oxygen radical-mediated LDL peroxidation. Purified human LDL were oxidized by exposure to oxygen free radicals generated by xanthine (0.2 mM) and xanthine oxidase (100 mU) at 37°C after a pre-incubation (30 min) in presence of different concentrations (from 1 to 30 μM) of acebutolol, metoprolol or propranolol, three agents with a different degree of lipophilicity. Peroxidation was measured from malonyldihaldehyde (MDA) production. Data have shown a significant percent inhibition of MDA formation in presence of β-blockers (from 33 to 85%). Thus, β-blockers reduced peroxidation of human LDL in vitro at clinically relevant concentrations. The order of potency appears to follow the degree of lipophilicity. These data suggest that, although β-blockers are known to adversely effect lipid metabolism, these agents might on the other hand prevent atherogenesis via a mechanism of inhibition of LDL peroxidation in vivo and reduced foam cells formation.

KW - β-blockers

KW - LDL

KW - oxygen radicals

KW - peroxidation

UR - http://www.scopus.com/inward/record.url?scp=0028302726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028302726&partnerID=8YFLogxK

M3 - Articolo

C2 - 7914499

AN - SCOPUS:0028302726

VL - 24

SP - 361

EP - 366

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 0046-5968

IS - 4

ER -